aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАНateroskleroz-23Research ArticleОБЗОРЫREVIEWSГИПОЛИПИДЕМИЧЕСКИЕ СРЕДСТВА: ВОЗМОЖНОСТИ И ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ. СООБЩЕНИЕ 3. ПРИМЕНЕНИЕ СТАТИНОВ У ОТДЕЛЬНЫХ КАТЕГОРИЙ БОЛЬНЫХHYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 3. STATIN’S USING IN DIFFERENT PATIENT’S CATEGORYБагрийА. Э.BagriyA. E.bagriyae@mail.ruДядыкА. И.DyadykA. I.noemail@neicon.ruХоменкоМ. В.KhomenkoM. V.noemail@neicon.ruЦыбаИ. Н.TsibaI. N.noemail@neicon.ruЕфременкоВ. А.EfremenkoV. A.noemail@neicon.ruЩукинаЕ. В.SchukinaE. V.noemail@neicon.ruПриколотаО. А.PrikolotaO. A.noemail@neicon.ruДонецкий Национальный медицинский университет им.М.ГорькогоDonetsk National Medical University name M. Gorky2016270920191236177Copyright © Багрий А.Э., Дядык А.И., Хоменко М.В., Цыба И.Н., Ефременко В.А., Щукина Е.В., Приколота О.А., 20192019Багрий А.Э., Дядык А.И., Хоменко М.В., Цыба И.Н., Ефременко В.А., Щукина Е.В., Приколота О.А.Bagriy A.E., Dyadyk A.I., Khomenko M.V., Tsiba I.N., Efremenko V.A., Schukina E.V., Prikolota O.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/23

В статье представлены вопросы, касающиеся применения статинов у пациентов различных клинических групп, включая атеросклероз-ассоциированные сердечно-сосудистые заболевания, артериальную гипертензию, сахарный диабет, хроническую болезнь почек, семейные гиперхолестеринемии, больных ревматологического и гастроэнтерологического профиля.

This article is devoted to discussion about statin’s using in patients with atherosclerosis-associated disease, arterial hypertension, diabetes mellitus, chronic kidney disease, familial hypercholesterolaemia, rheumatoid arthritis, systemic lupus erythematosus, nonalcoholic fatty liver disease and gallstone disease.

статиныатеросклероз-ассоциированные заболеваниясемейные гиперхолестеринемииstatinsatherosclerosis-associated diseasefamilial hypercholesterolaemiaReferencesАронов Д.М., Арабидзе Г.Г., Ахмеджанов Н.М. и др. Диагностика и коррекция нарушений ли-пидного обмена с целью профилактики и лече-ния атеросклероза. Российские рекомендации (Vпересмотр) М. 2012. 50 с. [Электронный ресурс]:www.scardio.ru/content/Guidelines/rek_lipid_2012. pdfАронов Д.М., Арабидзе Г.Г., Ахмеджанов Н.М. и др. Диагностика и коррекция нарушений ли-пидного обмена с целью профилактики и лече-ния атеросклероза. Российские рекомендации (Vпересмотр) М. 2012. 50 с. [Электронный ресурс]:www.scardio.ru/content/Guidelines/rek_lipid_2012. pdfБритов А.Н., Поздняков Ю.М., Волкова Э.Г. и др. Национальные рекомендации по кардиоваску- лярной профилактике // Кардиоваскулярная те- рапия и профилактика≫, 2011, № 10 (Приложение 2). 64 с.Бритов А.Н., Поздняков Ю.М., Волкова Э.Г. и др. Национальные рекомендации по кардиоваску- лярной профилактике // Кардиоваскулярная те- рапия и профилактика≫, 2011, № 10 (Приложение 2). 64 с.Кутишенко Н. П., Толпыгина С. Н., Лукина Ю. В. и др. Национальные рекомендации по эффек-тивности и безопасности лекарственной терапии при первичной и вторичной профилактике сер-дечно-сосудистых заболеваний // Рацион. фарма-котер. кардиол. 2011. Т.7, №3 (Приложение). 72 с.Кутишенко Н. П., Толпыгина С. Н., Лукина Ю. В. и др. Национальные рекомендации по эффек-тивности и безопасности лекарственной терапии при первичной и вторичной профилактике сер-дечно-сосудистых заболеваний // Рацион. фарма-котер. кардиол. 2011. Т.7, №3 (Приложение). 72 с.Bittner V. Selecting Patients for Statin Therapy inPrimary Prevention If We Could Only Predict theFuture // J. Amer. Coll. Cardiol. 2015. Vol. 65, N 21,P. 2710-2712.Bittner V. Selecting Patients for Statin Therapy inPrimary Prevention If We Could Only Predict theFuture // J. Amer. Coll. Cardiol. 2015. Vol. 65, N 21,P. 2710-2712.Stone N.J. , Robinson J. , Lichtenstein A.H. et al.ACC/AHA Guideline on the treatment of bloodcholesterol to reduce atherosclerotic cardiovascularrisk in adults // J. Amer. Coll. Cardiol. - 2014. -Vol.63, № 25. - P. 2889-2934.Stone N.J. , Robinson J. , Lichtenstein A.H. et al.ACC/AHA Guideline on the treatment of bloodcholesterol to reduce atherosclerotic cardiovascularrisk in adults // J. Amer. Coll. Cardiol. - 2014. -Vol.63, № 25. - P. 2889-2934.Opie L.H., Gersh B.J. Drugs for the heart. - Elsevier,2013. - 592 p.Opie L.H., Gersh B.J. Drugs for the heart. - Elsevier,2013. - 592 p.Чазова И.Е., Ратова Л.Г., Бойцов С.А.и др. Диа-гностика и лечение артериальной гипертензии.Клинические рекомендации // Системные гипер-тензии. 2010. №3 С. 5-26.Чазова И.Е., Ратова Л.Г., Бойцов С.А.и др. Диа-гностика и лечение артериальной гипертензии.Клинические рекомендации // Системные гипер-тензии. 2010. №3 С. 5-26.Drozda J. P., Ferguson Т. B., Hani Jneid et al. 2015ACC/AHA Focused Update of Secondary PreventionLipid Performance Measures. A Report of the ACC/AHA/ // J. Amer. Coll. Cardiol. 2016. Vol. 67, N 5.P.558-587.Drozda J. P., Ferguson Т. B., Hani Jneid et al. 2015ACC/AHA Focused Update of Secondary PreventionLipid Performance Measures. A Report of the ACC/AHA/ // J. Amer. Coll. Cardiol. 2016. Vol. 67, N 5.P.558-587.Reiner Z., Catapano A.L., De Baker G. et al. ESC/EAS Guidelines for the management of dyslipidaemias.The Task Force for the management of dyslipidaemiasof the European Society of Cardiology (ESC) and theEuropean Atherosclerosis Society (EAS) // Eur. HeartJ. 2011. Vol. 32. P. 1769-1818.Reiner Z., Catapano A.L., De Baker G. et al. ESC/EAS Guidelines for the management of dyslipidaemias.The Task Force for the management of dyslipidaemiasof the European Society of Cardiology (ESC) and theEuropean Atherosclerosis Society (EAS) // Eur. HeartJ. 2011. Vol. 32. P. 1769-1818.Weber M.A., Schiffrin E.L., White W.B. et al. Clinicalpractice guidelines for the management of hypertensionin the community: a statement by the AmericanSociety of Hypertension and the International Societyof Hypertension // J. Clin. Hypertens. - 2013. - Ре-жим доступа к журн.: http://csc.cma.org.cn/attachment/2014315/1394885445745.pdfWeber M.A., Schiffrin E.L., White W.B. et al. Clinicalpractice guidelines for the management of hypertensionin the community: a statement by the AmericanSociety of Hypertension and the International Societyof Hypertension // J. Clin. Hypertens. - 2013. - Ре-жим доступа к журн.: http://csc.cma.org.cn/attachment/2014315/1394885445745.pdfMancia G., Fagard R., Narkiewicz K. et al. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management ofarterial hypertension // J. Hypertens. 2013. Vol. 31. P.1281-1357.Mancia G., Fagard R., Narkiewicz K. et al. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management ofarterial hypertension // J. Hypertens. 2013. Vol. 31. P.1281-1357.Kellum J.A., Lameire N., Aspelin P. et al. KDIGOClinical Practice Guideline for the Management ofBlood Pressure in Chronic Kidney Disease // KidneyInt. 2012. Vol. 2 (Suppl.). P. 337-414.Kellum J.A., Lameire N., Aspelin P. et al. KDIGOClinical Practice Guideline for the Management ofBlood Pressure in Chronic Kidney Disease // KidneyInt. 2012. Vol. 2 (Suppl.). P. 337-414.James Р.А., Oparil S., Carter B.L. et al. Evidence-Based guideline for the management of high bloodpressure in adults: Report From the Panel MembersAppointed to the Eighth Joint National Committee(JNC 8) // J. Amer. Med. Ass. - 2014. Vol. 311, N 5.P. 507-520.James Р.А., Oparil S., Carter B.L. et al. Evidence-Based guideline for the management of high bloodpressure in adults: Report From the Panel MembersAppointed to the Eighth Joint National Committee(JNC 8) // J. Amer. Med. Ass. - 2014. Vol. 311, N 5.P. 507-520.Eckel R.H., Jakicic J.M., Ard J.D. et al. AHA/ACC Guideline on lifestyle management to reducecardiovascular risk // Circulation. - 2013. - 46 р. -Режим доступа к журн.: http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437740.48606.d1.full.pdf.Eckel R.H., Jakicic J.M., Ard J.D. et al. AHA/ACC Guideline on lifestyle management to reducecardiovascular risk // Circulation. - 2013. - 46 р. -Режим доступа к журн.: http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437740.48606.d1.full.pdf.Jensen M.D., Ryan D.H., Apovian C.M. et al.AHA/ACC/TOS Guideline for the management of overweight and obesity in adults // J. Amer. Coll.Cardiol. 2014. Vol.63. № 25. P.2995-3023.Jensen M.D., Ryan D.H., Apovian C.M. et al.AHA/ACC/TOS Guideline for the management of overweight and obesity in adults // J. Amer. Coll.Cardiol. 2014. Vol.63. № 25. P.2995-3023.Classification and Diagnosis of Diabetes. AmericanDiabetes Association Standards of Medical Care inDiabetes 2016 (Sec. 2) // Diabetes Care. 2016. Vol.39 (Suppl 1). P.S39-S46. Режим доступа к журн.:http://care.diabetesjournals.org/site/misc/2016-Standards-of-Care.pdfClassification and Diagnosis of Diabetes. AmericanDiabetes Association Standards of Medical Care inDiabetes 2016 (Sec. 2) // Diabetes Care. 2016. Vol.39 (Suppl 1). P.S39-S46. Режим доступа к журн.:http://care.diabetesjournals.org/site/misc/2016-Standards-of-Care.pdfGlycemic Targets. American Diabetes AssociationStandards of Medical Care in Diabetes 2016 (Sec. 5)// Diabetes Care. 2016. Vol. 39 (Suppl 1). P.S39-S46.Glycemic Targets. American Diabetes AssociationStandards of Medical Care in Diabetes 2016 (Sec. 5)// Diabetes Care. 2016. Vol. 39 (Suppl 1). P.S39-S46.Approaches to glycemic treatment. American DiabetesAssociation Standards of Medical Care in Diabetes2016 (Sec. 7)// Diabetes Care. 2016. Vol.39 (Suppl. 1)P. S52-S59.Approaches to glycemic treatment. American DiabetesAssociation Standards of Medical Care in Diabetes2016 (Sec. 7)// Diabetes Care. 2016. Vol.39 (Suppl. 1)P. S52-S59.Cardiovascular disease and risk management.American Diabetes Association Standards of MedicalCare in Diabetes 2016 (Sec. 8)// Diabetes Care. 2016.Vol.39 (Suppl. 1). P. S60-S71.Cardiovascular disease and risk management.American Diabetes Association Standards of MedicalCare in Diabetes 2016 (Sec. 8)// Diabetes Care. 2016.Vol.39 (Suppl. 1). P. S60-S71.Microvascular complications and foot care AmericanDiabetes Association Standards of Medical Care inDiabetes 2016 (Sec. 9)// Diabetes Care. 2016. Vol.39(Suppl. 1). P. S72-S80.Microvascular complications and foot care AmericanDiabetes Association Standards of Medical Care inDiabetes 2016 (Sec. 9)// Diabetes Care. 2016. Vol.39(Suppl. 1). P. S72-S80.Карпов Ю.А., Кухарчук В.В., Лякишев А.А. и др.Диагностика и лечение хронической ишемиче-ской болезни сердца. Клинические рекомендацииМЗ России. М. 2013. 69 с. [Электронный ресурс]: http://medi.ru/doc/a030923.htmКарпов Ю.А., Кухарчук В.В., Лякишев А.А. и др.Диагностика и лечение хронической ишемиче-ской болезни сердца. Клинические рекомендацииМЗ России. М. 2013. 69 с. [Электронный ресурс]: http://medi.ru/doc/a030923.htmAntman E.M., Jessup M. Clinical practice guidelinesfor chronic cardiovascular disorders: a roadmap for thefuture // J. Amer. Med. Ass. -2014. - Vol. 311, № 12.- P. 1195-1196.Antman E.M., Jessup M. Clinical practice guidelinesfor chronic cardiovascular disorders: a roadmap for thefuture // J. Amer. Med. Ass. -2014. - Vol. 311, № 12.- P. 1195-1196.Montalescot G., Sechtem U., Achenbach S. et al.Guidelines on the management of stable coronaryartery disease [Электронный ресурс] // Eur. HeartJ. - 2013. - 32 p. - Режим доступа: http://www.escardio.org/guidelines7surveys/esc7guidelines/GuidelinesDocuments/2013_Stable_ Coronary_Artery_ Disease_web_addenda.pdf.Montalescot G., Sechtem U., Achenbach S. et al.Guidelines on the management of stable coronaryartery disease [Электронный ресурс] // Eur. HeartJ. - 2013. - 32 p. - Режим доступа: http://www.escardio.org/guidelines7surveys/esc7guidelines/GuidelinesDocuments/2013_Stable_ Coronary_Artery_ Disease_web_addenda.pdf.Campos-Outcalt D. The new cardiovascular diseaseprevention guidelines: what you need to know // J.Fam. Pract. - 2014. -Vol. 63, № 2. - P. 89-93.Campos-Outcalt D. The new cardiovascular diseaseprevention guidelines: what you need to know // J.Fam. Pract. - 2014. -Vol. 63, № 2. - P. 89-93.Аронов Д.М., Бубнова М.Г., Барбараш О.Л. и др.Острый инфаркт миокарда с подъемом сегментаST электрокардиограммы: реабилитация и вто-ричная профилактика. Российские клиническиерекомендации. М., 2014. 159 c.Аронов Д.М., Бубнова М.Г., Барбараш О.Л. и др.Острый инфаркт миокарда с подъемом сегментаST электрокардиограммы: реабилитация и вто-ричная профилактика. Российские клиническиерекомендации. М., 2014. 159 c.O’Gara P.T., Kushner F.G., Ascheim D.D. et al.2013 ACCF/AHA Guideline for the Managementof ST-Elevation Myocardial Infarction: A Reportof the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines [Электронный ресурс] //Circulation.-2013. - 89 р. - Режим доступа: http://circ.ahajournals.org/ content/127/4/e362.full.pdf+html.O’Gara P.T., Kushner F.G., Ascheim D.D. et al.2013 ACCF/AHA Guideline for the Managementof ST-Elevation Myocardial Infarction: A Reportof the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines [Электронный ресурс] //Circulation.-2013. - 89 р. - Режим доступа: http://circ.ahajournals.org/ content/127/4/e362.full.pdf+html.Amsterdam E.A., Wener N.K., Brindis R.G.et al.2014 AHA/ACC Guideline for the Management ofPatients With Non-ST-Elevation Acute CoronarySyndromes: Executive Summary A Report of theACC/AHA Task Force on Practice Guidelines //Circulation. 2014. Vol.130. P. e431-e432.Amsterdam E.A., Wener N.K., Brindis R.G.et al.2014 AHA/ACC Guideline for the Management ofPatients With Non-ST-Elevation Acute CoronarySyndromes: Executive Summary A Report of theACC/AHA Task Force on Practice Guidelines //Circulation. 2014. Vol.130. P. e431-e432.Murphy S. A., Cannon C. P., Blazing M. A. Reductionin Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome TheIMPROVE-IT Trial/ // J. Amer. Coll. Cardiol. 2016.Vol. 67. P. 353-361Murphy S. A., Cannon C. P., Blazing M. A. Reductionin Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome TheIMPROVE-IT Trial/ // J. Amer. Coll. Cardiol. 2016.Vol. 67. P. 353-361Wright R. S., Murphy J. PROVE-IT to IMPROVE-ITWhy LDL-C Goals Still Matter in Post-ACS Patients// J. Amer. Coll. Cardiol. 2016. Vol. 67, N 4, P.362-364Wright R. S., Murphy J. PROVE-IT to IMPROVE-ITWhy LDL-C Goals Still Matter in Post-ACS Patients// J. Amer. Coll. Cardiol. 2016. Vol. 67, N 4, P.362-364Jauch E.C., Saver J.L., Adams H.P. et al. AHA/ASA Guidelines for the management of patients withacute ischemic stroke [Электронный ресурс] //Stroke. - 2013. - 87 p. - Режим доступа: http://stroke.ahajournals.org/content/early/2013/01/31/STR.0b013e318284056a. full. pdf.Jauch E.C., Saver J.L., Adams H.P. et al. AHA/ASA Guidelines for the management of patients withacute ischemic stroke [Электронный ресурс] //Stroke. - 2013. - 87 p. - Режим доступа: http://stroke.ahajournals.org/content/early/2013/01/31/STR.0b013e318284056a. full. pdf.Kernan W.N., Ovbiagele B., Black H.R. et al.Guidelines for the prevention of stroke in patientswith stroke and transient ischemic attack: a guidelinefor healthcare professionals from the American HeartAssociation/American Stroke Association [Элек-тронный ресурс] // Stroke. - 2014. - 94 р. - Ре-жим доступа: http://stroke.ahajournals.org/content/early/2014/04/30/STR.0000000000000024.full.pdf+html.Kernan W.N., Ovbiagele B., Black H.R. et al.Guidelines for the prevention of stroke in patientswith stroke and transient ischemic attack: a guidelinefor healthcare professionals from the American HeartAssociation/American Stroke Association [Элек-тронный ресурс] // Stroke. - 2014. - 94 р. - Ре-жим доступа: http://stroke.ahajournals.org/content/early/2014/04/30/STR.0000000000000024.full.pdf+html.Davies S.M., Donnan G.A. Secondary Preventionafter Ischemic Stroke or Transient Ischemic Attack //N. Engl. J. Med. 2012. Vol.366. P. 1914-1922.Davies S.M., Donnan G.A. Secondary Preventionafter Ischemic Stroke or Transient Ischemic Attack //N. Engl. J. Med. 2012. Vol.366. P. 1914-1922.Squizzato A, Romualdi E, Dentali F, Ageno W: Statinsfor acute ischemic stroke // Cochrane Database Syst.Rev. 2011. Vol. 8. CD007551.Squizzato A, Romualdi E, Dentali F, Ageno W: Statinsfor acute ischemic stroke // Cochrane Database Syst.Rev. 2011. Vol. 8. CD007551.Моисеев В.С., Мухин Н.А., Смирнов А.В. и др.Сердечно-сосудистый риск и хроническая бо-лезнь почек: стратегии кардио- и нефропротек-ции. Национальные рекомендации / // Рос. кар-диол. журн. 2014 № 8 С. 7-37.Моисеев В.С., Мухин Н.А., Смирнов А.В. и др.Сердечно-сосудистый риск и хроническая бо-лезнь почек: стратегии кардио- и нефропротек-ции. Национальные рекомендации / // Рос. кар-диол. журн. 2014 № 8 С. 7-37.Levin A., Stevens P.E., Bilous R.W. et al. KDIGOClinical Practice Guideline for the Evaluation andManagement of Chronic Kidney Disease // KidneyInt. 2012. Vol. 3 (Suppl.). P. 123-150.Levin A., Stevens P.E., Bilous R.W. et al. KDIGOClinical Practice Guideline for the Evaluation andManagement of Chronic Kidney Disease // KidneyInt. 2012. Vol. 3 (Suppl.). P. 123-150.The Kidney (9th ed. /M.W. Taal, G.M. Chertow,P.A. Marsden. et al./ Philadelphia: Brenner andRector’s, 2012. - 3064 p.The Kidney (9th ed. /M.W. Taal, G.M. Chertow,P.A. Marsden. et al./ Philadelphia: Brenner andRector’s, 2012. - 3064 p.Palmer S.C., Craig J.C., Navaneethan S.D. et al.Benefits and harms of statin therapy for personswith chronic kidney disease: a systematic review andmetaanalysis // Ann. Intern. Med. 2012. Vol. 157. P.263-275Palmer S.C., Craig J.C., Navaneethan S.D. et al.Benefits and harms of statin therapy for personswith chronic kidney disease: a systematic review andmetaanalysis // Ann. Intern. Med. 2012. Vol. 157. P.263-275Baigent C. Cholesterol Metabolism and StatinEffectiveness in Hemodialysis Patients // J. Amer.Coll. Cardiol. 2015. Vol. 65, N. 21, P. 2299-2301.Baigent C. Cholesterol Metabolism and StatinEffectiveness in Hemodialysis Patients // J. Amer.Coll. Cardiol. 2015. Vol. 65, N. 21, P. 2299-2301.Bogaert Y.E., Chonchol M. Assessing the benefitsand harms of statin treatment in patients with chronickidney disease // Nat. Clin. Pract. Nephrol. - 2008. -Vol. 4. - P. 470-471.Bogaert Y.E., Chonchol M. Assessing the benefitsand harms of statin treatment in patients with chronickidney disease // Nat. Clin. Pract. Nephrol. - 2008. -Vol. 4. - P. 470-471.Eknoyan G., Lameire N., Eckardt K.U. et al. KDIGOClinical Practice Guideline for Lipid Management inChronic Kidney Disease // Kidney Int. - 2013. - Vol.3 (Suppl.). - P. 1-56.Eknoyan G., Lameire N., Eckardt K.U. et al. KDIGOClinical Practice Guideline for Lipid Management inChronic Kidney Disease // Kidney Int. - 2013. - Vol.3 (Suppl.). - P. 1-56.Rooke T.W., Hirsch A.T., Misra S. et al. ACCF/AHA Focused Update of the Guideline for theManagement of Patients With Peripheral ArteryDisease (Updating the 2005 Guideline): A Reportof the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines [Электронный ресурс] // Circulation. -2011. - Режим доступа: http://circ.ahajournals.org/content/124/18/2020.full.Rooke T.W., Hirsch A.T., Misra S. et al. ACCF/AHA Focused Update of the Guideline for theManagement of Patients With Peripheral ArteryDisease (Updating the 2005 Guideline): A Reportof the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines [Электронный ресурс] // Circulation. -2011. - Режим доступа: http://circ.ahajournals.org/content/124/18/2020.full.Grundy S. M., Arai H., Barter P. et al. Globalrecommendations for the management of dyslipidemia.(Expert Dyslipidemia Panel. An InternationalAtherosclerosis Society Position Paper) // J. Clin.Lipidol. 2013. Vol. 7. P. 561-565.Grundy S. M., Arai H., Barter P. et al. Globalrecommendations for the management of dyslipidemia.(Expert Dyslipidemia Panel. An InternationalAtherosclerosis Society Position Paper) // J. Clin.Lipidol. 2013. Vol. 7. P. 561-565.Silva V.S., Martin L.C., Franko R.J.S. et al.Pleiotropic effects of statins may improve outcomesin atherosclerotic renovascular disease // Amer.J.Hypertens. 2008. Vol. 21. № 10. P. 1163-1168.44. Cooper C.J., Murphy T.P., Cutlip D.E. et al. Stentingand medical therapy for atherosclerotic renal arterystenosis // N. Engl. J. Med. 2014. Vol. 370. № 1. P.13-22.Silva V.S., Martin L.C., Franko R.J.S. et al.Pleiotropic effects of statins may improve outcomesin atherosclerotic renovascular disease // Amer.J.Hypertens. 2008. Vol. 21. № 10. P. 1163-1168.44. Cooper C.J., Murphy T.P., Cutlip D.E. et al. Stentingand medical therapy for atherosclerotic renal arterystenosis // N. Engl. J. Med. 2014. Vol. 370. № 1. P.13-22.Покровский А.В., Сокуренко Г.Ю., СамородскаяИ.В. и др. Национальные рекомендации по веде-нию пациентов с заболеваниями брахиоцефаль-ных артерий // Ангиол. сосуд. хирургия. 2013. №2. С. 5-62.Покровский А.В., Сокуренко Г.Ю., СамородскаяИ.В. и др. Национальные рекомендации по веде-нию пациентов с заболеваниями брахиоцефаль-ных артерий // Ангиол. сосуд. хирургия. 2013. №2. С. 5-62.Ramos R., Garcia-Gil M., Comas-Cufi M. et al.Statins for Prevention of Cardiovascular Events in aLow-Risk Population With Low Ankle Brachial Index// J. Amer. Coll. Cardiol. 2016. Vol.67. P. 630-640.Ramos R., Garcia-Gil M., Comas-Cufi M. et al.Statins for Prevention of Cardiovascular Events in aLow-Risk Population With Low Ankle Brachial Index// J. Amer. Coll. Cardiol. 2016. Vol.67. P. 630-640.Nordestgaard B.G., Chapman M.J., Humphries S.E. etal. Familial hypercholesterolaemia is underdiagnosedand undertreated in the general population: guidancefor clinicians to prevent coronary heart disease.Consensus Statement of the European AtherosclerosisSociety // Eur. Heart J. 2013. Vol. 34. P. 3478-3490.Nordestgaard B.G., Chapman M.J., Humphries S.E. etal. Familial hypercholesterolaemia is underdiagnosedand undertreated in the general population: guidancefor clinicians to prevent coronary heart disease.Consensus Statement of the European AtherosclerosisSociety // Eur. Heart J. 2013. Vol. 34. P. 3478-3490.Watts G. F., Gidding S., Wierzbicki A.S. et al. Integratedguidance on the care of familial hypercholesterolemiafrom the International FH Foundation // J. Clin.Lipidol. 2014. Vol. 8. P. 148-172.Watts G. F., Gidding S., Wierzbicki A.S. et al. Integratedguidance on the care of familial hypercholesterolemiafrom the International FH Foundation // J. Clin.Lipidol. 2014. Vol. 8. P. 148-172.Van Leuven S.I., Mendez-Fernandez Y.V.,Wilhelm A.J. et al. Statin therapy in lupus-mediatedatherogenesis: two birds with one stone? // Ann.Rheum. Dis. 2011. Vol. 70, N2 P. 245-248Van Leuven S.I., Mendez-Fernandez Y.V.,Wilhelm A.J. et al. Statin therapy in lupus-mediatedatherogenesis: two birds with one stone? // Ann.Rheum. Dis. 2011. Vol. 70, N2 P. 245-248Martin-Martinez M.A., Gonzalez-Juanatey C.,Castaneda S. et al. Recommendations for themanagement of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion [Электронный ресурс] / Semin. Arthr. Rheum. - 2014. - Режим доступа: http://www.ser.es/wp-content/uploads/2015/09/ Evaluaci%C3%B3n_y_el_manejo_del_riesgo_ cardiovascular_en_los_pacientes_con_Artritis_ Reumatoide.pdfMartin-Martinez M.A., Gonzalez-Juanatey C.,Castaneda S. et al. Recommendations for themanagement of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion [Электронный ресурс] / Semin. Arthr. Rheum. - 2014. - Режим доступа: http://www.ser.es/wp-content/uploads/2015/09/ Evaluaci%C3%B3n_y_el_manejo_del_riesgo_ cardiovascular_en_los_pacientes_con_Artritis_ Reumatoide.pdfИвашкин В.Т., Драпкина О.М. Рекомендации по диагностике и лечению неалкогольной жировой болезни печени (НАЖБП). - М. 2012. 27 с.Ивашкин В.Т., Драпкина О.М. Рекомендации по диагностике и лечению неалкогольной жировой болезни печени (НАЖБП). - М. 2012. 27 с.Chalasani N., Younossi Z., Lavine J.E. et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association // Amer. J. Gastroenterol. 2012. Vol.107. P. 811-826.Chalasani N., Younossi Z., Lavine J.E. et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association // Amer. J. Gastroenterol. 2012. Vol.107. P. 811-826.Jukema J.W. ,Cannon C.P., de Craen A.J., et al. The controversies of statin therapy. Weighing the evidence // J. Amer. Coll. Cardiol. 2012. Vol. 60. P. 875-881.Jukema J.W. ,Cannon C.P., de Craen A.J., et al. The controversies of statin therapy. Weighing the evidence // J. Amer. Coll. Cardiol. 2012. Vol. 60. P. 875-881.Nseir W., Mahamid M. Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review// Curr. Atheroscler. Rew. 2013. Vol. 15. N 3. P. 152- 161.Nseir W., Mahamid M. Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review// Curr. Atheroscler. Rew. 2013. Vol. 15. N 3. P. 152- 161.Gomez-Dominguez E, Gisbert J.P., Moreno- Monteagudo J.A. et al. A pilot study of atorvastatin treatment in dyslipemic, non-alcoholic fatty liver patients // Aliment. Pharmacol. Ther. 2006. Vol. 23. P. 1643-1647.Gomez-Dominguez E, Gisbert J.P., Moreno- Monteagudo J.A. et al. A pilot study of atorvastatin treatment in dyslipemic, non-alcoholic fatty liver patients // Aliment. Pharmacol. Ther. 2006. Vol. 23. P. 1643-1647.Cariati A., Piromalli E. Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease // Expert Opin. Pharmacother. 2012. Vol. 13(9). P. 1223-1227.Cariati A., Piromalli E. Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease // Expert Opin. Pharmacother. 2012. Vol. 13(9). P. 1223-1227.Chiu H.F., Chen C.C., Kuo H.W. et al. Statin use and the risk of gallstone disease: a population-based casecontrol study // Expert Opin. Drug Saf. 2012. Vol. 11 (3). P. 369-374.Chiu H.F., Chen C.C., Kuo H.W. et al. Statin use and the risk of gallstone disease: a population-based casecontrol study // Expert Opin. Drug Saf. 2012. Vol. 11 (3). P. 369-374.Erichsen R., Froslev T., Lash T. L. et al. Long-term Statin Use and the Risk of Gallstone Disease: A Population-based Case-control Study // Amer. J. Epidemiol. 2011. Vol. 172 (2). P. 162-170.Erichsen R., Froslev T., Lash T. L. et al. Long-term Statin Use and the Risk of Gallstone Disease: A Population-based Case-control Study // Amer. J. Epidemiol. 2011. Vol. 172 (2). P. 162-170.Pulkkinen J. , Eskelinen M., Kiviniemi V. et al. Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study // BMC Gastroenterology. 2014. Vol. 14. P. 119-123.Pulkkinen J. , Eskelinen M., Kiviniemi V. et al. Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study // BMC Gastroenterology. 2014. Vol. 14. P. 119-123.Suuronen S., Niskanen L., Paajanen P., Paajanen H. Declining cholecystectomy rate during the era of statin use in Finland: a population-based cohort study between 1995 and 2009 // Scand. J. Surg. 2013. Vol. 102, N 3. P. 158-163.Suuronen S., Niskanen L., Paajanen P., Paajanen H. Declining cholecystectomy rate during the era of statin use in Finland: a population-based cohort study between 1995 and 2009 // Scand. J. Surg. 2013. Vol. 102, N 3. P. 158-163.Ruilope L.M. Long-term adherence to therapy: the clue to prevent hypertension consequences // Eur. Heart J. 2013. Vol. 34. P. 2931-2932.Ruilope L.M. Long-term adherence to therapy: the clue to prevent hypertension consequences // Eur. Heart J. 2013. Vol. 34. P. 2931-2932.

The authors declare that there are no conflicts of interest present.